Company ProfilePremium

Chitec Technology Co., Ltd.

Company Profile Analysis

奇鈦科技股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Chitec Technology Co., Ltd. - Company showcase

Year Founded & Workforce

1998

139 Employees

Chitec Technology Co., Ltd. logo

Chitec Technology Co., Ltd. Employee Contacts

5 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Chitec Technology Co., Ltd. Overview

Chitec is a small, research-led Taiwanese maker of polymer and coating additives. Its products protect materials from light and heat (UV absorbers, hindered-amine light stabilisers, antioxidants), cure them with light (photoinitiators) or make them flame-resistant. With about TWD 1.7 billion of revenue in FY2025 and two plants in Hsinchu and Changhua (Changbin), it competes against BASF, Songwon, SI Group and a large field of Chinese producers by avoiding commodity grades and selling patented, regulation-ready molecules such as Chiguard GA403, R-455 and 9546 and Revonox 501 and 420V. It supports these with FDA, EFSA, REACH and TSCA registrations and flexible small-batch production. More than 90% of sales are exported through over 20 distributors. Customers increasingly value it as a non-China source. The 2026 agenda is to turn blue-light absorbers and optical-grade additives into the next growth leg, enter electronic and battery materials, and defend a gross margin that has slipped from 28% to about 23–24%.


Company's own description. The corporate website states that Chitec "specializes in the research and development of high-performance chemical additives for various industries, including electronics, automotive, aerospace, construction, packaging, and synthetic fibers", with major product lines of UV stabilisers, antioxidants, photoinitiators and flame retardants. Its registered business scope is the R&D, production and sale of UV absorbers and light stabilisers, photoinitiators, and antioxidants and other specialty chemicals. The corporate tagline is "We pursue difference, not numbers."

Independent characterisation. Chitec is a pure-play, single-segment specialty additives formulator and synthesiser. It designs molecules, scales them in multi-purpose batch plants in Taiwan, secures regulatory clearances (food contact, REACH, TSCA) and sells mainly through distributors to compounders, resin makers, coatings and ink formulators and film makers. It sits in the middle of the value chain: upstream are petrochemical intermediates (phenols, amines, triazine and benzotriazole precursors, phosphorus chemistry); downstream are plastics compounders, coating and ink houses and optical-film and lens makers; end-markets are automotive, construction, packaging, consumer electronics, textiles and fibres, and printing.

Revenue model. Revenue is essentially all product sales priced per kilogram. No subscription, licensing or service revenue is disclosed. A small historical element is toll or OEM manufacturing: the Changhua plant started in 2014 producing flame retardant FCX-210 for Teijin Chemical. In September 2026 management said supply-chain realignment is creating new "strategic cooperation and toll-manufacturing opportunities".

Mix. Per the 23 September 2026 investor conference, the 2026 product mix is UV absorbers and light stabilisers 60%, antioxidants 22.3%, photoinitiators 15.4% and flame retardants 1.6%.

Margin structure by line (management Q&A, September 2026, against a 1H2026 blended gross margin of 24.21%): antioxidants are above average, UV absorbers and light stabilisers slightly below average, and photoinitiators below average because of intense competition.

Customer types. Global coatings majors (PPG approved Chitec UV absorbers in 2001), imaging companies (Eastman Kodak 2002, Carestream 2008), chemical majors (DuPont Supplier Quality Award 2012 and 2013; Chimei co-patent 1999; Teijin OEM 2014), PET packaging converters, optical film and lens makers, PCB ink formulators and engineering-plastic compounders for consumer electronics.

End-market framing on the company website. Coatings (automotive, industrial, wood); UV/LED curing and printing; adhesives and sealants; plastics (automotive and transportation, building and construction, packaging, agriculture, consumer goods, textiles and fibres, electrical and electronics); optical coatings.

Strategy

Stated strategic themes. The website's motto is "We pursue difference, not numbers", with innovation framed as "Greener, Safer, Effective". At the September 2026 conference management described its edge as molecular design, innovation, customer solutions and flexible production planning, and said it does not take part in commodity price wars.

Initiatives in the last 24 months

Financial guidance. For 2027 management is "conservatively optimistic", aiming for near double-digit revenue growth. It declined to forecast gross margin because of inflation and raw-material costs, but intends to hold it near the 2026 level through mix upgrade and cost pass-through. No formal medium-term margin, ROE or capex targets are disclosed. No cost-reduction programme with numeric targets was identified.

ESG commitments. ISO 14064-1 greenhouse-gas inventory in place. No quantified emissions-reduction target was found.

Products & Services

Chitec publishes four product families and a product selector on its website, and released a "2026 Plastic Additives Catalog" on 11 May 2026. Pricing is not disclosed for any product.

A. Verified flagship and named products

B.

Services. Application and technical service (weathering and physical-property testing), regulatory dossiers, a distributor platform and e-book shelf, the "Chitec Focus" newsletter, and toll manufacturing. A Shanghai application laboratory is planned to open in 2027.

Pipeline (September 2026 conference and press): additional blue-light absorbers; optical-grade additives; cathode and anode binder resins, dispersants and electrolyte components for non-China energy-storage customers; processing aids for engineering plastics in consumer electronics, electric vehicles and humanoid robots. A third-party research note, unconfirmed by the company in sources retrieved, reports EUV photoresist-related monomers and a dedicated high-cleanliness electronic-grade line.

Product Portfolio

Family / brandProductDescription and capabilityTarget useYear / status

UV stabilisers (Chiguard)

Chiguard GA403

Patented UV blocker; TSCA and REACH registered (2020); passed EFSA food-contact assessment (2026); China food-contact national standard applied for, expected 2027

PET packaging for food, pharma and personal care; also cited among blue-light products

Patented 2020; EU food contact 2026

UV stabilisers (Chiguard)

Chiguard R-445

Reactable (polymer-bound) UV absorber; global patents, TSCA/REACH

Coatings and polymers needing non-migrating UV protection

2020

UV stabilisers (Chiguard)

Chiguard R-455

Reactive/polymeric UV absorber technology; TCIA Product Innovation Award 2023; US invention patent June 2026; "2026 Innovative Material Award" September 2026

High-durability coatings, optical and engineering plastics

2023–2026

UV stabilisers (Chiguard)

Chiguard 9546 (BLA)

Blue-light absorber; Canadian notice of allowance July 2026; South Korean patent August 2026

Wearables, automotive displays, AR-HUD and smart windshields, optical films, blue-cut lenses

Commercialising 2026

UV stabilisers

KB403

Blue-light absorber named by management as in mass production

Blue-cut lenses, AR/VR displays, HUD

Mass production 2026

UV stabilisers (Chiguard)

Chiguard Wood Series

Light-stabiliser packages for wood coatings

Wood coatings

Featured September 2026

UV stabilisers

Anhydrous liquid additive series

Water-dispersible liquid additives without the storage and transport limits of emulsions

Waterborne coatings under VOC rules

Disclosed September 2026

Antioxidants (Revonox)

Revonox 501

Patented broad-spectrum, high-efficiency antioxidant; TSCA and FDA cleared; DT New Materials award 2025

Engineering plastics, polyolefins, food-contact uses

2011

Antioxidants (Revonox)

Revonox 420V

Phenol-free antioxidant derived from palm oil; FDA approved

Packaging and sustainability-positioned applications

2016

Antioxidants (Revonox)

Revonox 608

Antioxidant grade; packaging updated July 2026

Polymer processing stabilisation

Current

Antioxidants (Revonox series)

PCR stabilisation packages

Positioned for oxidation and colour stability of post-consumer recyclate under EU PPWR

Recycled plastics

Promoted March 2026

Antioxidants (legacy)

Chinox 850

Eco-friendly antioxidant for ABS, co-patented with Chimei

ABS resin

1999

Antioxidants (legacy)

Trisphenol antioxidant

Proprietary antioxidant

Carestream medical X-ray film

2008

Photoinitiators (Chivacure)

Chivacure TPO

Acylphosphine-oxide photoinitiator developed for optical-fibre coatings

Optical-fibre coatings, UV coatings and inks

2000

Photoinitiators (R-gen)

R-gen 990

Patented liquid photoinitiator for LED UV curing and black-ink systems

UV-LED inks, PCB inks, digital printing

2019

Flame retardants (Zuran)

Zuran series

Environment-oriented, non-halogen flame retardants

Engineering plastics, electronics

Current; order pick-up noted 2H2025

Flame retardants (OEM)

FCX-210

Toll production of Teijin Chemical's flame retardant at Changhua

Teijin (polycarbonate applications)

From 2014

FamilyIllustrative gradesChemistry

Chiguard UV absorbers

234, 326, 328, 5530, 1064

Benzotriazoles; hydroxyphenyl-triazine

Chiguard HALS

101, 770, 622, 944

Hindered-amine light stabilisers (liquid, monomeric and oligomeric)

Deox antioxidants

Deox 10, Deox 76, Deox 68

Hindered phenolics and phosphite

Chivacure photoinitiators

184, 173, TPO-L, BMS, DETX, ITX, EPD

Free-radical initiators and amine synergists

R-gen photoinitiators

Cationic sulfonium and iodonium grades

Cationic UV curing

Financial Narrative

All figures are TWD million unless stated. Source: S&P Global Market Intelligence via StockAnalysis.com. Dividends per share are attributed to the earnings year and paid the following year.

6.1 Income statement

Revenue CAGR FY2021–FY2025 is about 3.4% (analyst calculation). FY2024 pre-tax income includes a TWD 14.38 million unusual charge.

Commentary. Revenue peaked at TWD 1,598 million in FY2022, fell 21% in the FY2023 destocking, and recovered to a record TWD 1,711 million in FY2025. Profit did not follow. Gross margin dropped 5.3 points in FY2025 to 22.97%, the lowest of the five years, and net income of TWD 106 million was the lowest of the period. Three things explain this: a shift toward UV stabilisers and China volume (both below-average margin), photoinitiator price competition, and a swing from a TWD 18.6 million currency gain to a TWD 5.8 million loss. The effective tax rate also rose to 28.7%.

6.2 Balance sheet (year-end)

Commentary. The 2022 listing raised TWD 186.5 million and moved the company from net debt to net cash. Net cash has since fallen from TWD 308 million (FY2023) to TWD 218 million (FY2025) and TWD 186 million at 30 June 2026, as capex, receivables and inventory absorbed cash. At 30 June 2026 total debt was TWD 241 million after more than TWD 130 million of long-term borrowing for the Taipei office, and PP&E had risen to TWD 585 million.

6.3 Cash flow

Commentary. Free cash flow has fallen every year, from TWD 277 million to TWD 21 million, as capex rose more than fivefold (Changbin warehouse and laboratory) and working capital grew with sales. In the twelve months to June 2026 free cash flow was negative TWD 43 million on capex of TWD 232 million, which includes the Taipei office. FY2025 dividends of TWD 84 million exceeded free cash flow and were funded from the cash balance.

6.4 Ratios

Interest coverage and the cash-conversion components are analyst calculations on year-end balances. Other ratios are as reported by S&P.

Commentary. Returns have fallen with margin: ROE went from 23.5% (FY2022) to 9.4% (FY2025). Leverage is not a constraint. The cash conversion cycle of about 137 days reflects the roughly 140 days of inventory the company holds to serve many small customers through distributors.

6.5 Interim update: 1H2026 (company investor conference, 23 September 2026)

First-half revenue rose 27.7% and net income 119.5%. Operating margin was flat, so the earnings jump came from below the operating line. S&P shows a trailing-twelve-month currency gain of TWD 26.3 million to June 2026, against a TWD 5.8 million loss in FY2025. Trailing-twelve-month figures to 30 June 2026: revenue TWD 1,921 million, net income TWD 156 million, diluted EPS TWD 4.61. Revenue for January–August 2026 was TWD 1,305 million, up 21.51%.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Product Lines

Product line (% of revenue)FY20241H20252026 YTD

UV absorbers and light stabilisers (%)

5256.960

Antioxidants (%)

2825.722.3

Photoinitiators (%)

191715.4

Flame retardants and other (%)

10.41.6

Product Lines (FY2024–1H2026)

Product line (TWD Mn, implied)FY20241H20251H2026

UV absorbers and light stabilisers

766434584

Antioxidants

412196217

Photoinitiators

280130150

Flame retardants and other

15316

Total consolidated revenue

1,473762973

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (TWD Mn)

1,4971,5981,2621,4731,711

Revenue growth (%)

29.096.73-20.9816.6416.19

Cost of revenue (TWD Mn)

1,1511,173911.681,0561,318

Gross profit (TWD Mn)

346.05424.36350.80416.86393.04

SG&A (TWD Mn)

149.01171.76156.68189.48207.66

R&D expense (TWD Mn)

20.8642.5961.4129.2031.06

Operating income (TWD Mn)

176.51210.00132.71197.72154.56

EBITDA (TWD Mn)

237.85269.98184.90241.90199.09

Currency gain or loss (TWD Mn)

-3.7123.031.6118.56-5.75

Pre-tax income (TWD Mn)

173.68249.62155.68213.17149.07

Income tax (TWD Mn)

42.9153.4235.4451.8042.72

Net income (TWD Mn)

130.77196.20120.24161.37106.35

EPS basic (TWD)

4.406.333.574.793.15

EPS diluted (TWD)

4.366.263.544.763.14

Dividend per share (TWD)

2.003.002.002.501.60

Gross margin (%)

23.1226.5627.7928.3122.97

Operating margin (%)

11.7913.1410.5113.439.03

EBITDA margin (%)

15.8916.9014.6416.4311.64

Net margin (%)

8.7312.289.5210.966.22

Effective tax rate (%)

24.7121.4022.7624.3028.66

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (TWD Mn)

1,2131,4591,4341,5911,646

Cash and equivalents (TWD Mn)

124.59419.19423.73402.40321.47

Cash and short-term investments (TWD Mn)

143.19424.75433.63452.04336.11

Receivables (TWD Mn)

210.10194.84172.77199.03260.87

Inventory (TWD Mn)

407.42387.34421.55477.42502.31

Property, plant and equipment (TWD Mn)

417.32378.61358.75357.74414.55

Total debt incl. leases (TWD Mn)

216.42154.83125.37153.91118.48

Short-term debt incl. current portions (TWD Mn)

62.1724.3820.0120.3837.71

Long-term debt incl. leases (TWD Mn)

154.25130.45105.35133.5280.77

Net debt, negative = net cash (TWD Mn)

73.23-269.92-308.26-298.14-217.63

Total liabilities (TWD Mn)

545.00455.70413.62466.86504.68

Shareholders' equity (TWD Mn)

667.671,0031,0201,1241,141

Goodwill (TWD Mn)

00000

Other intangibles (TWD Mn)

1.371.053.121.990.97

Working capital (TWD Mn)

398.46721.75761.01847.89742.77

Book value per share (TWD)

22.4529.7530.2633.3433.84

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (TWD Mn)

296.94262.92150.06142.83129.39

Capital expenditure (TWD Mn)

20.1031.6531.6284.98108.37

Free cash flow (TWD Mn)

276.84231.27118.4457.8521.02

Dividends paid (TWD Mn)

14.5859.47101.1567.4384.29

Share buybacks (TWD Mn)

00000

Share issuance (TWD Mn)

0186.47000

Net debt issued or repaid (TWD Mn)

-233.96-62.16-29.7013.80-35.30

Depreciation and amortisation (TWD Mn)

68.3367.3559.8251.8452.03

Change in working capital (TWD Mn)

139.03-20.473.44-46.88-19.26

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

21.4323.4811.8815.059.39

ROA (%)

9.239.835.738.175.97

ROIC (%)

16.5722.3914.1819.4612.61

Current ratio (x)

2.083.403.723.872.97

Quick ratio (x)

0.952.062.172.211.58

Debt / equity (x)

0.320.150.120.140.10

Net debt / EBITDA (x)

0.31-1.00-1.67-1.23-1.09

Interest coverage, EBIT / interest (x)

44.775.553.969.661.1

Asset turnover (x)

1.251.200.870.971.06

Inventory turnover (x)

2.812.952.252.352.69

Days sales outstanding (days)

4942494755

Days inventory (days)

129121169165139

Days payable (days)

6041605258

Cash conversion cycle (days)

119122158161137

Income Statement and Margin Analysis (%) (1H2025–1H2026)

Metric1H20251H2026

Revenue (TWD Mn)

762973

Gross profit (TWD Mn)

—235

Gross margin (%)

—24.21

Operating income (TWD Mn)

—112

Operating margin (%)

11.5611.57

Net income (TWD Mn)

4190

EPS (TWD)

1.212.68

Revenue by Region (%)

Region (% of revenue)FY20241H2026

Taiwan (%)

118.6

Asia excluding Taiwan (%)

5256.5

of which China (%)

—43.6

of which other Asia (%)

—12.9

Americas / North America (%)

2726.2

Europe (%)

88.7

“—” = not publicly disclosed.

Revenue by Region

Region (TWD Mn, implied)FY20241H2026

Taiwan

16284

Asia excluding Taiwan

766550

Americas / North America

398255

Europe

11885

Capital Markets Data (TWD) and Market Valuation

MetricFY2021FY2022FY2023FY2024FY2025

Year-end adjusted close (TWD)

44.2736.2043.2756.0560.54

Market capitalisation (TWD Mn)

1,6001,4311,6082,0132,067

Enterprise value (TWD Mn)

1,8021,1931,2751,7451,866

P/E (x)

12.237.3013.3812.4719.43

EV/EBITDA (x)

7.584.426.907.219.37

EV/Sales (x)

1.200.751.011.191.09

P/B (x)

2.401.431.581.791.81

Dividend per share (TWD)

2.003.002.002.501.60

Dividend yield (%)

4.528.294.624.462.64

Payout ratio (%)

11.1530.3184.1241.7979.26

Valuation Snapshot

MetricValue

Market capitalisation (TWD Mn)

3,827

Enterprise value (TWD Mn)

3,641

Trailing P/E (x)

24.63

EV/EBITDA (x)

15.83

EV/Sales (x)

1.90

P/B (x)

3.23

Dividend yield (%)

1.41

Beta, 5-year

2.09

52-week price change, as of 24 Sep 2026 (%)

97.02

50-day / 200-day moving average (TWD)

110.58 / 102.44

20-day average volume (shares)

261,424

Analyst Conclusions

Management guidance. For 2027: near double-digit revenue growth, gross margin held near the 2026 level if possible, and net profit growth driven by volume. New unit at 3% of revenue in 2027 and 8% in 2028. Patented products at 10–12% of revenue within five years. No 2026 full-year numeric guidance was given.

Consensus. None. On the eight-month run rate, FY2026 revenue should land close to TWD 2 billion; this is an analyst inference and not a company forecast.

Bull case

  1. Volume momentum is broad. Every product line grew in 1H2026; eight-month revenue is up 21.5%; trailing EPS of TWD 4.61 already matches the FY2024 level.

  2. The portfolio is moving up the value curve. Blue-light absorbers are in mass production, GA403 has EU food-contact clearance with China targeted for 2027, and three patents were granted in mid-2026.

  3. Chitec is a rare non-China, Taiwan-based additive source with spare capacity for one to two years of growth, net cash, and a possible strategic investor.

Bear case

  1. The quality of the 2026 earnings recovery is doubtful. Operating margin was flat at 11.57%; the EPS jump came from currency and a low base. Gross margin of 24.2% is still four points below FY2024.

  2. China at 43.6% of sales is partly stocking ahead of a shipping scare. A reversal in 2027 would fall on a higher fixed-cost base (new warehouse, laboratory, owned head office).

  3. At 24.6 times trailing earnings and 15.8 times EBITDA, with negative free cash flow, no analyst coverage, a beta above 2 and possible 24% dilution, the stock already prices in the blue-light and battery story.

Catalysts and things to watch over the next 12 months

  • 3Q2026 results (about 13 November 2026): gross margin against 24.2%, and the currency line.

  • Monthly revenue through 4Q2026 and 1Q2027 for signs of China destocking.

  • Execution and pricing of the private placement, and the identity of any strategic investor.

  • First disclosed revenue from blue-light absorbers and from the Electronic and Battery Materials unit.

  • China food-contact approval for GA403.

  • Opening of the Shanghai application lab and completion of the Changbin laboratory.

  • Regulatory decisions on benzotriazole UV absorbers.

  • Photoinitiator pricing.

Analyst verdict. Chitec is a credible small specialist caught between two stories. The first is real. A 28-year-old additives house with regulatory files, patents and blue-chip approvals is selling record volumes, and customers want a supplier outside China. Revenue has grown at double-digit rates for two and a half years. The product news in 2026 (EFSA clearance for GA403, patents for R-455 and 9546, two blue-light products in production) is evidence of a working innovation pipeline.

The second story is less comfortable. Growth has come with lower margins. Gross margin fell from 28.3% to 23.0% in FY2025, and FY2025 net income was the weakest in five years on record sales. The 1H2026 rebound in EPS owes more to currency than to operations. The largest market, China, is also the one most distorted by temporary stocking and most exposed to local competitors. Free cash flow has turned negative as the company builds a warehouse, a laboratory and buys its head office. Reported R&D spending is modest for a business that sells differentiation.

The balance sheet removes any solvency concern, and management's targets (near double-digit growth in 2027, 3% then 8% of revenue from battery and electronic materials, 10–12% from patented products) are measurable. The issue is price. The shares have roughly doubled in a year to 24.6 times trailing earnings without analyst coverage, and a discounted private placement could add up to 24% more stock.

Our assessment: operationally improving, strategically well placed, financially sound, but with unproven margin recovery and a valuation that assumes it. Two numbers will settle the argument: gross margin returning toward 26–28%, and the first reported sales from blue-light and battery materials. Until those appear, the evidence supports a growing company more than a re-rated one.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleBackgroundTenure / notes

Long Hsiao-Fen (龍筱芬)

Chairman and President

EMBA, National Taiwan Normal University; accounting studies, Essex County College, Newark, New Jersey

Chairman in all current sources; also director and GM of the Shanghai subsidiary since 15 December 2023

Lin Ting-Ting (林婷婷)

AVP Finance & Accounting; spokesperson

Accounting, National Taiwan University; NTU EMBA

Head of finance since 2003 (MarketScreener)

Yang Hsiu-Fang (楊秀芳)

AVP Sales & Marketing; deputy spokesperson

Accounting, Soochow University

—

Yao Sung-Fang (姚頌芳)

AVP Sales & Marketing (as introduced at the September 2026 conference)

——

Wu Huang-Min (吳皇旻)

Head of R&D

MSc Chemistry, National Tsing Hua University

—

Tsai Kuei-Ping (蔡貴平)

Senior Plant Director

Chemical Engineering and EMBA, National Tsing Hua University

—

Lo Tang-Yu (羅棠榆)

Hsinchu Plant Director

MSc Chemical Engineering, NTUST

—

Chu Te-Chang (曲德昌)

Special Assistant to the Chairman; director

Mathematics and Economics, University of Toronto; ex-Wedbush Securities risk analyst; ex-AIG investment analyst; CFA

First-degree relative of the chairman

Hsieh Shang-Yu (謝尚祐)

Special Assistant to the Chairman

MSc, Institute of Nuclear Science, National Tsing Hua University

—

Chung Cho-Chi (鍾卓冀)

Special Assistant to the Chairman; director

MSc Shipping Management, National Taiwan Ocean University; former supervisor of the company

—

Long Hsiao-Fen

Chairman, representing Yi-De Specialty Chemical Investment Co., Ltd.

2,393,797 (entity)

As above

Chu Te-Chang

Director

1,460,601

As above

Chung Cho-Chi

Director

6,000

As above

Chen Ching-Ling (陳靖玲)

Independent director

0

Master of Accounting, University of Illinois; chairman of a financial advisory firm

Chen Chih-Wei (陳致瑋)

Independent director

0

MA Administrative Management, California State University, Los Angeles

Shao Chung-Yi (邵仲益)

Independent director

0—

Yeh Yu-Lin (葉玉琳)

Independent director

0—

“—” = not publicly disclosed.

Major Shareholders

HolderShares / lotsStake (%)Source

Long Hsiao-Fen, personal

2,973 lots

8.82

Fubon/MOPS, June 2026

Yi-De Specialty Chemical Investment Co., Ltd. (controlled by Long)

2,394 lots

7.10

Fubon/MOPS; registry

Chu Te-Chang

1,460,601 shares

4.33

Registry

All directors

3,870 lots

11.5

Goodinfo, August 2026

Insiders, S&P definition

—18.39

StockAnalysis

Institutions, S&P definition

—2.46

StockAnalysis

Domestic individuals

27,904 lots

82.8

Goodinfo, 2026

Domestic corporates

4,300 lots

12.8

Goodinfo, 2026

Foreign investors

1,512 lots

4.48 (Goodinfo) or 6.18 (Cnyes)

Sources differ

Competitive Landscape

Competitors by Segment

Product lineNamed competitorsPositioning relative to Chitec

UV absorbers and HALS

BASF (Tinuvin, Chimassorb); Syensqo, formerly Solvay (Cyasorb); Clariant; Songwon; SI Group; ADEKA; Sabo; Rianlon; Everlight Chemical (Eversorb); Double Bond Chemical

Global majors hold formulation approvals and scale. Chinese producers lead on cost. Everlight and Double Bond are the closest Taiwanese peers

Antioxidants

BASF (Irganox, Irgafos); Songwon; SI Group; ADEKA; Rianlon

A commodity market at the base. Chitec plays in niches (Revonox 501, 420V)

Photoinitiators

IGM Resins; Tianjin Jiuri New Materials; Changzhou Tronly; Double Bond Chemical; Arkema (Sartomer)

Third-party research describes Chitec as one of five principal global suppliers alongside IGM and Chinese producers. It is the lowest-margin line

Flame retardants

ICL; Lanxess; ADEKA; Clariant; Teijin (as customer and peer)

Chitec is sub-scale at 1–2% of revenue

Peer Comparison FY2025

MetricChitec (TTM to Jun 2026)Everlight Chemical 1711.TW (TTM to Jun 2026)

Revenue (TWD Mn)

1,9217,820

Revenue growth (%)

27.94—

Gross margin (%)

22.6020.2

Operating margin (%)

9.31

negative to break-even

R&D intensity (%)

1.774.8

Company Snapshot

$55M

Revenue

139

Employees

$128M

Market Cap

1998

Founded

SWOT Analysis

Strengths

  • Record revenue of TWD 1,711 million in FY2025 and TWD 1,921 million in the twelve months to June 2026, with eight-month 2026 revenue up 21.51%.
  • Net cash of TWD 186 million at 30 June 2026; debt to equity 0.20; EBIT covers interest more than 45 times.
  • Regulatory assets: more than 30 REACH registrations (2018), FDA clearances for Revonox 501 and 420V, EFSA assessment for GA403 (2026).
  • Recent patents in three jurisdictions in three months (US for R-455; Canada and Korea for 9546).
  • Customer credentials: PPG (2001), Kodak (2002), DuPont Supplier Quality Award (2012–2013), Teijin OEM (2014).
  • All production in Taiwan (Hsinchu, Changbin), ISO 9001, 14001, 45001 and 14064-1 certified, with spare capacity for one to two years of growth.
  • More than 20 distributors on five continents, with a new Brazilian partner in September 2026.

Weaknesses

  • Gross margin fell from 28.31% (FY2024) to 22.97% (FY2025); operating margin from 13.43% to 9.03%.
  • Net income of TWD 106 million in FY2025 was the lowest in five years; ROE fell to 9.39%.
  • Free cash flow fell from TWD 277 million (FY2021) to TWD 21 million (FY2025) and was negative TWD 43 million in the twelve months to June 2026.
  • R&D of about 1.8% of revenue is low against a research-led claim, and below Everlight Chemical's roughly 4.8%.
  • Photoinitiators (15–19% of sales) earn below-average margin, by management's own admission.
  • Governance concentration: combined chairman and CEO; chairman and a director are first-degree relatives; family group holds about 20%.
  • Thin market following: no analysts submitting estimates (Simply Wall St); institutions hold 2.46%; five-year beta 2.09.

Opportunities

  • Blue-light absorbers: two products in mass production, with management expecting sales to build over one to two years.
  • GA403 in food-contact PET: EU cleared in 2026, China approval targeted for 2027.
  • New Electronic and Battery Materials unit targeting 3% of revenue in 2027 and 8% in 2028.
  • Non-China sourcing demand and toll-manufacturing offers from international customers.
  • Patented products targeted to reach 10–12% of revenue in five years.
  • PPWR-driven recycled-plastics stabilisation and waterborne-coating additives.
  • A strategic investor through the proposed private placement of up to 8 million shares.

Threats

  • China concentration at 43.6% of 1H2026 revenue, inflated by stocking ahead; management itself flags a high base.
  • Chinese competitors in photoinitiators and commodity stabilisers.
  • Raw-material and inflation pressure, with no 2027 margin guidance.
  • Currency swings moving pre-tax profit by tens of millions of TWD a year.
  • Dilution of up to about 24% of current shares if the full placement is issued at a discount (floor 80% of reference price).
  • Execution risk in battery materials, where Chitec has no disclosed track record.
  • Tightening chemical regulation can also remove legacy benzotriazole grades from Chitec's own catalogue.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
2025 (date not specified)Revonox 501 wins Innovative Material Award from DT New MaterialsBrand recognition in China engineering plastics
1H 2025Revenue TWD 762 million; net income TWD 41 million; EPS TWD 1.21; operating margin 11.56%Weak first-half base
Aug 2025Monthly revenue TWD 184 million, a record; up 43.03% month on month and 35.53% year on year. Eight-month revenue TWD 1,074 million, up 9.15%Start of the volume upswing
12 Sep 2025Online investor conference; 1H2025 mix disclosed (UV 56.9%, antioxidants 25.7%, photoinitiators 17%, flame retardants 0.4%); flame-retardant orders rising in 2HProduct mix tilting to UV
Nov 2025Monthly revenue TWD 163 million, up 43.15%; eleven-month revenue TWD 1,535 million, up 15.5%Sustained recovery
Jan 2026FY2025 revenue reported at TWD 1,711 million, up 16.19%, a recordTop-line record
Feb 2026January revenue TWD 171 million, up 21.59%; company highlights engineering-plastic processing aids for consumer electronics, EVs and humanoid robotsHigh-end positioning
11 Mar 2026Board approves private placement proposal (up to 8 million shares and/or convertible bonds)Potential dilution of about 24%
Mar 2026FY2025 results: net income TWD 106 million; EPS TWD 3.15; gross margin 22.97%Profit down 34% despite record sales
Mar 2026Company publishes PPWR and recycled-plastics positioning for RevonoxRegulatory-driven demand theme
2026 (date not specified)Chiguard GA403 passes EFSA food-contact assessmentOpens EU, Middle East and South American packaging
11 May 2026"2026 Plastic Additives Catalog" releasedMarketing
26 May 2026Share price about TWD 169 (Stoxray)Year-to-date peak area
25 May and 17 Jun 2026Authorised capital raised to TWD 500 million, then TWD 700 millionHeadroom for placement or convertibles
2 Jun 2026US invention patent granted for R-455 polymer technologyIP
Early Jun 2026May revenue TWD 141 million, up 6.25%; five-month revenue TWD 802 million, up 22.52%Growth moderating month to month
9 Jun 2026AGM: full re-election of board; non-compete release for new directors; cash dividend of TWD 1.60 per share (about TWD 54 million)Governance refresh
16 Jun 2026"Post-UV-326 Era" product strategy articlePositions substitutes for restricted UV absorbers
23 Jun 2026Announces co-exhibit with InfoChems at ATEM FAIR 2026Korea display market
9 Jul 2026Ex-dividend dateCapital return
15 Jul 2026Revonox 608 packaging updateProduct housekeeping
23 Jul 2026Smart manufacturing project, Chitec × IIIOperations
27 Jul 2026Spectral-management technology presented at ATEM FAIRBlue-light marketing
30 Jul 2026Canadian notice of allowance for Chiguard 9546IP
10 Aug 2026July revenue TWD 152 million, up 18.61%Continued growth
12 Aug 2026Board approves 2Q2026 consolidated financials1H EPS TWD 2.68
17 Aug 2026Six key solutions previewed for TaipeiPLAS 2026"From material protection to light management"
18 Aug 2026South Korean patent for Chiguard 9546IP
10 Sep 2026To exhibit at PIAC 2026Marketing
21 Sep 2026Chiguard R-455 wins 2026 Innovative Material AwardRecognition
23 Sep 2026Investor conference: eight-month revenue TWD 1,305 million, up 21.51%; new business unit; 2027 guidance; Shanghai lab; office purchaseKey strategic update
24 Sep 2026Share price up 5.63% to TWD 112.50Market reaction
26 Sep 2026MCassab appointed distributor in BrazilLatin America
30 Sep 2026TaipeiPLAS 2026 participationMarketing

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue rose from TWD 1,497 Mn in FY2021 to TWD 1,711 Mn in FY2025.
Chitec Technology Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (TWD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue1,4971,5981,2621,4731,711
Cost of revenue1,1511,173911.71,0561,318
Gross profit346.1424.4350.8416.9393

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.